Research in Progress: "Trials of Clinical Reminders Using the Electronic Medical Record"
All research in progress seminars are off-the-record. Any information about methodology and/or results are embargoed until publication.
Abstract:
One of the important benefits of an electronic medical record is the potential to provide targeted decision support and reminders for care. In addition to improving care these reminders serve a secondary purpose of documenting care that is now required for public reporting or pay for performance programs. Thus, there is pressure to add an ever increasing number of reminders with unclear consequences. I will review past studies using computerised reminders and present several randomized trials conducted or planned at the Palo Alto VA and Stanford hospitals. The goals of these reminders include increasing life-prolonging heart failure medications and device use, reducing inappropriate cardiac imaging, and rapid treatment for sepsis. Clinical reminders can be considered quality improvement and I will discuss the potential for conducting methodologically rigorous randomized reminder trials that are not "research".
CHP/PCOR Conference Room
117 Encina Commons, Room 119
Stanford, CA 94305
Paul A. Heidenreich
VA Palo Alto Medical Center
111C Cardiology
3801 Miranda Avenue
Palo Alto, CA 94304
Paul Heidenreich MD, MS is Professor and Vice-Chair for Clinical, Quality, and Analytics in the Department of Medicine. He also directs VA's Quality Enhancement Research Initiative (QUERI) in Medication Management and the Echocardiography Laboratory at the VA Palo Alto Health Care System. His research focuses on interventions to improve the quality of care for heart disease patients; the use of echocardiography to predict prognosis; the cost-effectiveness of new cardiovascular technologies; and outcomes research using existing clinical and administrative data. His administrative efforts focuses on measuring, improving, and disseminating the quality of care provided by faculty in the Department of Medicine.